Skip to content

Brunswick 公司

US · BC #2256 按市值排名 上市于 1970
64.37 -1.26 -1.92%
实时 - 追踪5344个代码 - 心跳于47秒前 · 2026-10-16 19:30

最新新闻

  • 评级变动
    Research Report Insights | China Galaxy Securities: Maintains "Recommended" rating on Hengrui Pharma, citing continued delivery from its innovative pipeline and further enhancement of its BC matrix.
    Gelonghui Finance · 2026/7/8
  • 评级变动
    Baird Maintains Brunswick Corp(BC.US) With Hold Rating, Raises Target Price to $92
    \u5e02\u573a\u8d44\u8baf · 2026/7/31
  • 评级变动
    Meikolando (600882): Q2 delivers strong growth, with BC continuing to drive momentum together.
    Caitong Securities · 2026/7/8
  • 评级变动
    Longi Green Energy (601012): BC capacity will ramp up rapidly in 2025, with copper paste expected to enter mass production and adoption in June.
    Changjiang Securities · 2026/6/9
  • 评级变动
    KeyBanc Maintains Brunswick Corp(BC.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/8/12
  • Truist Financial Upgrades Brunswick Corp(BC.US) to Buy Rating, Raises Target Price to $94
    \u5e02\u573a\u8d44\u8baf · 2026/7/6
  • 公司公告
    Paltac: We have launched "Nice2meet," the industry's first B2B matching site specializing in the H&BC sector.
    JPX · 2026/3/2
  • Hehe Information (688615) Commentary: Facing phased pressure; in the short term, it is influenced by commercial big data B/C.
    Shenwan Hongyuan Research · 2026/8/23
  • 公司公告
    Chewy | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BC Partners Holdings Limited(60.44%),CIE Management IX Limited(60.44%), etc.
    SEC · 2024/11/7
  • 评级变动
    Roth MKM Maintains Brunswick Corp(BC.US) With Buy Rating, Maintains Target Price $94
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    Morgan Stanley Maintains Brunswick Corp(BC.US) With Hold Rating, Maintains Target Price $86
    \u5e02\u573a\u8d44\u8baf · 2026/8/5
  • 公司公告
    BSLCORP: Notice of Person Ceasing (Section 139 of CA 2016) - BC MEDICARE SDN. BHD.
    Bursa Malaysia · 2024/4/29
  • D.A. Davidson Initiates Brunswick Corp(BC.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/8/17
  • 公司公告
    Investment Announcement by Bayi Iron & Steel on the Dual Preheating Replacement Project for Blast Furnace No. 2500 (BC) at the Ironmaking Plant
    SZSI · 2026/3/30
  • J.P. Morgan Maintains Brunswick Corp(BC.US) With Hold Rating, Cuts Target Price to $80
    \u5e02\u573a\u8d44\u8baf · 2026/8/5
  • 评级变动
    Truist Financial Maintains Brunswick Corp(BC.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/8/13
  • 公司公告
    Announcement Regarding Investment and Construction of Longi Green Energy Technology Photovoltaic (Xixian New Area) Phase I 12.5GW High Efficiency BC Battery Project.
    SZSI · 2024/7/13
  • 评级变动
    Hengrui Pharma (600276): Its innovative pipeline continues to deliver, and the BC matrix has been further refined.
    China Galaxy Securities · 2026/7/6
  • 评级变动
    A Quick Look at Today's Ratings for Brunswick Corp(BC.US), With a Forecast Between $86 to $94
    \u5e02\u573a\u8d44\u8baf · 2026/7/31

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

Brunswick 公司 讨论区 0 条评论

发表评论